Azimuth Capital Management’s Edwards Lifesciences EW Stock Holding History

Azimuth Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	$12M	Buy	102,107 +1,347	+1%	+$159K	0.51%	69
2021 Q4	$13.1M	Sell	100,760 -668	-0.7%	-$86.5K	0.53%	69
2021 Q3	$11.5M	Sell	101,428 -193	-0.2%	-$21.9K	0.49%	75
2021 Q2	$10.5M	Buy	101,621 +1,707	+2%	+$177K	0.45%	80
2021 Q1	$8.36M	Sell	99,914 -39	-0%	-$3.26K	0.4%	91
2020 Q4	$9.12M	Sell	99,953 -77,877	-44%	-$7.1M	0.45%	82
2020 Q3	$14.2M	Buy	177,830 +23,126	+15%	+$1.85M	0.84%	35
2020 Q2	$10.7M	Buy	154,704 +870	+0.6%	+$60.1K	0.68%	53
2020 Q1	$9.67M	Buy	153,834 +12,030	+8%	+$756K	0.73%	47
2019 Q4	$11M	Buy	141,804 +2,496	+2%	+$194K	0.67%	53
2019 Q3	$10.2M	Sell	139,308 -30,216	-18%	-$2.21M	0.67%	51
2019 Q2	$10.4M	Buy	169,524 +5,478	+3%	+$337K	0.69%	49
2019 Q1	$10.5M	Sell	164,046 -34,146	-17%	-$2.18M	0.7%	42
2018 Q4	$10.1M	Sell	198,192 -3,495	-2%	-$178K	0.77%	41
2018 Q3	$11.7M	Buy	201,687 +5,916	+3%	+$343K	0.78%	38
2018 Q2	$9.5M	Sell	195,771 -2,235	-1%	-$108K	0.68%	50
2018 Q1	$9.21M	Sell	198,006 -4,995	-2%	-$232K	0.68%	49
2017 Q4	$7.63M	Buy	203,001 +6,735	+3%	+$253K	0.55%	68
2017 Q3	$7.15M	Sell	196,266 -23,004	-10%	-$838K	0.54%	74
2017 Q2	$8.64M	Sell	219,270 -11,625	-5%	-$458K	0.68%	48
2017 Q1	$7.24M	Sell	230,895 -1,080	-0.5%	-$33.9K	0.58%	61
2016 Q4	$7.25M	Sell	231,975 -33,240	-13%	-$1.04M	0.62%	58
2016 Q3	$10.7M	Buy	265,215 +5,322	+2%	+$214K	0.93%	31
2016 Q2	$8.64M	Sell	259,893 -38,739	-13%	-$1.29M	0.77%	42
2016 Q1	$8.78M	Buy	298,632 +42,840	+17%	+$1.26M	0.84%	40
2015 Q4	$6.73M	Buy	255,792 +5,490	+2%	+$145K	0.66%	53
2015 Q3	$5.93M	Buy	250,302 +6,810	+3%	+$161K	0.62%	53
2015 Q2	$5.78M	Buy	243,492 +10,440	+4%	+$248K	0.56%	58
2015 Q1	$5.53M	Buy	233,052 +9,612	+4%	+$228K	0.54%	63
2014 Q4	$4.74M	Buy	+223,440	New	+$4.74M	0.49%	69